Lux Biosciences is a clinical stage biotechnology company
specialized in the field of ophthalmic diseases.
We are developing novel medications to treat the underlying causes of
ophthalmic diseases and alleviate their symptoms, and if these products are
approved by regulatory authorities, we intend to commercialize them.
With two first-in-class products currently in Phase 3 clinical development
and several innovative, highly promising earlier stage projects, we have
made significant progress towards building a revenue-generating,
high-growth, and sustainable ophthalmic company.